FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approves a supplemental labeling change for SELZENTRY (maraviroc) submitted by ViiV Healthcare Company, updating the product labeling for its use in HIV-1 i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Selzentry (Maraviroc)

Snippet

SUPPL AP for SELZENTRY (MARAVIROC)